PD-1 Produkte
(Programmed Cell Death 1 (PDCD1))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte PD-1 Kategorien
PD-1 Antikörper
High quality antibodies with extensive validation data.
PD-1 ELISA Kits
Reliable ELISA kits for a wide range of species.
PD-1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene PD-1 Antikörper
- (2)
- (3)
- (1)
- (8)
- (5)
Empfohlene PD-1 ELISA Kits
- (1)
- (1)
- (1)
- (1)
Empfohlene PD-1 Proteine
- (6)
- (6)
- (5)
Neueste Publikationen zu unseren PD-1 Produkten
: "Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents. ..." in: Cancer immunology research, Vol. 9, Issue 12, pp. 1451-1464, (2022) (PubMed).: "Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors." in: JCI insight, Vol. 6, Issue 20, (2021) (PubMed).
: "Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth." in: Molecular therapy oncolytics, Vol. 17, pp. 9-20, (2020) (PubMed).
: "An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses." in: Nature communications, Vol. 11, Issue 1, pp. 1395, (2020) (PubMed).
: "Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors." in: EMBO molecular medicine, Vol. 12, Issue 6, pp. e11571, (2020) (PubMed).
: "Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity." in: Cancer immunology, immunotherapy : CII, (2020) (PubMed).
: "Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma." in: PLoS ONE, Vol. 13, Issue 7, pp. e0201222, (2019) (PubMed).
: "Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." in: Journal of the National Cancer Institute, Vol. 110, Issue 3, pp. 316-320, (2019) (PubMed).
: "Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection." in: PLoS pathogens, Vol. 15, Issue 3, pp. e1007311, (2019) (PubMed).
: "Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion." in: Oncogenesis, Vol. 8, Issue 3, pp. 17, (2019) (PubMed).
Synonyme und alternative Namen zu PD-1
programmed cell death 1 (PDCD1), programmed cell death 1 (Pdcd1), CD279, hPD-1, hPD-l, Ly101, PD-1, PD1, Pdc1, SLEB2Bezeichner auf Proteinebene für PD-1
- programmed cell death protein 1
- protein PD-1
- programmed cell death 1
- programmed death 1
- mPD-1